FREE Daily Stock Alerts From Stock-PR.com
Crown Equity Holdings Inc. (OTCPK:CRWE)
CRWE is extending its internet footprint internationally to include the following countries; Argentina, Brazil, Canada, China, France, Germany, Hong Kong, India, Indonesia, Italy, Japan, Korea, Malaysia, Mexico, New Zealand, Pakistan, Russia, Singapore, Spain, South Africa, Taiwan, United Arab Emirates and United Kingdom.
Crown Equity Holdings Inc. is pleased to report its financial results for the nine month period ending September 30, 2010. Revenue for the nine months totaled $1,073,383 compared to $418,959 during 2009.
CRWE is a consulting organization which provides and assists small business owners with the knowledge required in taking their company public, and has re-focused CRWE’s primary vision with its aligned group of independent website divisions to providing media advertising services, as a worldwide online media advertising publisher, dedicated to the distribution of quality branding information, as well as search engine optimization for its clients.
To learn more about CRWE visit: http://www.crownequityholdings.com
PTS, Inc. (OTCPK:PTSH)
PTS, Inc announced this month after the market closed that Raj Kalra has been named Chairman and Chief Executive Officer, effective immediately. Mr. Kalra replaces Teresa Rubio who has served as Chairman and Marc Pintar who has served as PTSH Interim Chief Executive Officer. In addition to his role as CEO, Mr. Kalra will serve on PTSH 's Board of Directors.
"I'm very pleased to be named the CEO of PTSH," said Raj Kalra. "I am working very hard to bring value to our shareholders. My first order of business is to announce that PTSH , via ThinLine, has been granted a contract to develop and manage the modifications to a certain proprietary cloud computer software solution that ThinLine created based on the client's requirements for an online inventory management system for contracts that they manage for cable operators nationally." Raj Kalra continued, "This system tracks the sales process and contract maintenance between the cable operator and the property owner/investment company. It also tracks revenue sharing that is owed to the property based on right-of-entry agreements or tracking of bulk cable/internet agreements for the units of the property. This is a very meaningful contract for PTSH and shareholders will be advised of any additional developments as they unfold."
PTSH intends to acquire undervalued businesses and/or merge with businesses with a history of operating revenues. Prior to February 23, 2010, PTSH engaged in the provision of accessibility compliance consulting services to government, school districts, and municipalities and other public entities, as well as to retail, commercial, recreational, and corporate customers. PTS, Inc. was founded in 1996 and is based in Las Vegas, Nevada.
To learn more about PTSH visit: http://www.ptspi.com
Angiotech Pharmaceuticals Inc. (Nasdaq:ANPI) announced that it had released its financial results for the third quarter ended September 30, 2010. In addition, Angiotech also announced today that it had entered into an updated and amended credit facility and Forbearance Agreement with Wells Fargo Capital Finance, LLC ("Wells Fargo"). The updated and amended credit facility will provide us with up to $35 million of liquidity, with the applicable interest rate and other material terms being consistent with our current credit facility with Wells Fargo, except that the updated and amended credit facility is expected to increase our borrowing base, thereby assuring us immediate access to approximately $25 million under the facility, and provides for amended levels of material financial covenants.
Angiotech Pharmaceuticals, Inc., a global specialty pharmaceutical and medical device company, discovers, develops, and markets technologies and medical products primarily for local diseases or for complications associated with medical device implants, surgical interventions, and acute injury.
Sunesis Pharmaceuticals Inc. (Nasdaq:SNSS) announced updated data from Phase 2 clinical trials of the Company's lead drug candidate, vosaroxin, in combination with cytarabine, a widely used chemotherapy, in relapsed/refractory acute myeloid leukemia (AML) and as a single agent in frontline elderly AML. The data were presented today by Robert Stuart, M.D., Professor of Medicine, Division of Hematology/Oncology, Department of Medicine, Medical University of South Carolina, at the Chemotherapy Foundation Symposium XXVIII in New York City. The presentation is available on the Sunesis website at www.sunesis.com.
Sunesis Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of oncology therapeutics for the treatment of solid and hematologic cancers. Its lead product candidate is Voreloxin, an anticancer quinolone derivative (AQD) for the treatment of cancer.
NGAS Resources Inc. (Nasdaq:NGAS) reported third quarter 2010 total revenue of $11.0 million, compared to $11.2 million for the comparable quarter in 2009. Results for the quarter reflect a 19% increase in contract drilling revenue offset by lower production and higher transportation costs. Oil and gas production revenue was down 10% in the quarter reflecting a 15% production decline partially offset by slightly higher natural gas prices. For the quarter, the company reported a net loss of $2.5 million, compared to a net loss of $1.1 million in third quarter 2009. Loss per share was $0.06, compared with a $0.04 loss per share in the same period last year.
NGAS Resources, Inc., together with its subsidiaries, engages in the exploration and production of natural gas shale plays in the eastern United States principally in the southern Appalachian Basin.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer).Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (OTCPK:CRWE) has received five thousand dollars and anticipates receiving another forty five thousand dollars in cash from a third party for (thirty) days of advertising for PTS Inc. (OTCPK:PTSH).
Sign Up For Free Stock Alerts At http://stock-pr.com/signup
The views expressed in any article, reports, writings are not necessarily the views of Crown Equity Holdings Inc. its officers, directors, staff, contractors or employees. They do not represent the views or opinions of this site. Views expressed in articles are those of the author alone.